Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report aims to provide a comprehensive presentation of the global market for Flu (Influenza) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu (Influenza) Vaccine. This report contains market size and forecasts of Flu (Influenza) Vaccine in global, including the following market information:
Global Flu (Influenza) Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Flu (Influenza) Vaccine Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Flu (Influenza) Vaccine companies in 2022 (%)
The global Flu (Influenza) Vaccine market was valued at US$ 5664.4 million in 2022 and is projected to reach US$ 7180 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
We surveyed the Flu (Influenza) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu (Influenza) Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Type, 2022 (%)
Split Influenza Vaccine
Pandemic Influenza Vaccine
Subunit Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Flu (Influenza) Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Application, 2022 (%)
For Children (6 months to 3 years)
For Adults and Children over 3 years
Global Flu (Influenza) Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu (Influenza) Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Flu (Influenza) Vaccine revenues share in global market, 2022 (%)
Key companies Flu (Influenza) Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Flu (Influenza) Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Flu (Influenza) Vaccine, market overview.
Chapter 2: Global Flu (Influenza) Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Flu (Influenza) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu (Influenza) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Flu (Influenza) Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Flu (Influenza) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Flu (Influenza) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Flu (Influenza) Vaccine Overall Market Size
2.1 Global Flu (Influenza) Vaccine Market Size: 2022 VS 2030
2.2 Global Flu (Influenza) Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Flu (Influenza) Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Flu (Influenza) Vaccine Players in Global Market
3.2 Top Global Flu (Influenza) Vaccine Companies Ranked by Revenue
3.3 Global Flu (Influenza) Vaccine Revenue by Companies
3.4 Global Flu (Influenza) Vaccine Sales by Companies
3.5 Global Flu (Influenza) Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Flu (Influenza) Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Flu (Influenza) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Flu (Influenza) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Flu (Influenza) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Flu (Influenza) Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Flu (Influenza) Vaccine Market Size Markets, 2022 & 2030
4.1.2 Split Influenza Vaccine
4.1.3 Pandemic Influenza Vaccine
4.1.4 Subunit Influenza Vaccine
4.1.5 Quadrivalent Influenza Vaccine
4.2 By Type - Global Flu (Influenza) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Flu (Influenza) Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Flu (Influenza) Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
4.3 By Type - Global Flu (Influenza) Vaccine Sales & Forecasts
4.3.1 By Type - Global Flu (Influenza) Vaccine Sales, 2018-2023
4.3.2 By Type - Global Flu (Influenza) Vaccine Sales, 2024-2030
4.3.3 By Type - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2030
4.4 By Type - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Flu (Influenza) Vaccine Market Size, 2022 & 2030
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - Global Flu (Influenza) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Flu (Influenza) Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Flu (Influenza) Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
5.3 By Application - Global Flu (Influenza) Vaccine Sales & Forecasts
5.3.1 By Application - Global Flu (Influenza) Vaccine Sales, 2018-2023
5.3.2 By Application - Global Flu (Influenza) Vaccine Sales, 2024-2030
5.3.3 By Application - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2030
5.4 By Application - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Flu (Influenza) Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Flu (Influenza) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Flu (Influenza) Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Flu (Influenza) Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Flu (Influenza) Vaccine Sales & Forecasts
6.3.1 By Region - Global Flu (Influenza) Vaccine Sales, 2018-2023
6.3.2 By Region - Global Flu (Influenza) Vaccine Sales, 2024-2030
6.3.3 By Region - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Flu (Influenza) Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Flu (Influenza) Vaccine Sales, 2018-2030
6.4.3 US Flu (Influenza) Vaccine Market Size, 2018-2030
6.4.4 Canada Flu (Influenza) Vaccine Market Size, 2018-2030
6.4.5 Mexico Flu (Influenza) Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Flu (Influenza) Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Flu (Influenza) Vaccine Sales, 2018-2030
6.5.3 Germany Flu (Influenza) Vaccine Market Size, 2018-2030
6.5.4 France Flu (Influenza) Vaccine Market Size, 2018-2030
6.5.5 U.K. Flu (Influenza) Vaccine Market Size, 2018-2030
6.5.6 Italy Flu (Influenza) Vaccine Market Size, 2018-2030
6.5.7 Russia Flu (Influenza) Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Flu (Influenza) Vaccine Market Size, 2018-2030
6.5.9 Benelux Flu (Influenza) Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Flu (Influenza) Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Flu (Influenza) Vaccine Sales, 2018-2030
6.6.3 China Flu (Influenza) Vaccine Market Size, 2018-2030
6.6.4 Japan Flu (Influenza) Vaccine Market Size, 2018-2030
6.6.5 South Korea Flu (Influenza) Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Flu (Influenza) Vaccine Market Size, 2018-2030
6.6.7 India Flu (Influenza) Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Flu (Influenza) Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Flu (Influenza) Vaccine Sales, 2018-2030
6.7.3 Brazil Flu (Influenza) Vaccine Market Size, 2018-2030
6.7.4 Argentina Flu (Influenza) Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, 2018-2030
6.8.3 Turkey Flu (Influenza) Vaccine Market Size, 2018-2030
6.8.4 Israel Flu (Influenza) Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Flu (Influenza) Vaccine Market Size, 2018-2030
6.8.6 UAE Flu (Influenza) Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Hualan Bio
7.1.1 Hualan Bio Company Summary
7.1.2 Hualan Bio Business Overview
7.1.3 Hualan Bio Flu (Influenza) Vaccine Major Product Offerings
7.1.4 Hualan Bio Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Hualan Bio Key News & Latest Developments
7.2 CCBIO
7.2.1 CCBIO Company Summary
7.2.2 CCBIO Business Overview
7.2.3 CCBIO Flu (Influenza) Vaccine Major Product Offerings
7.2.4 CCBIO Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 CCBIO Key News & Latest Developments
7.3 Aleph Biomedical
7.3.1 Aleph Biomedical Company Summary
7.3.2 Aleph Biomedical Business Overview
7.3.3 Aleph Biomedical Flu (Influenza) Vaccine Major Product Offerings
7.3.4 Aleph Biomedical Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Aleph Biomedical Key News & Latest Developments
7.4 SANOFI
7.4.1 SANOFI Company Summary
7.4.2 SANOFI Business Overview
7.4.3 SANOFI Flu (Influenza) Vaccine Major Product Offerings
7.4.4 SANOFI Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 SANOFI Key News & Latest Developments
7.5 Adimmune
7.5.1 Adimmune Company Summary
7.5.2 Adimmune Business Overview
7.5.3 Adimmune Flu (Influenza) Vaccine Major Product Offerings
7.5.4 Adimmune Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Adimmune Key News & Latest Developments
7.6 ZYAK
7.6.1 ZYAK Company Summary
7.6.2 ZYAK Business Overview
7.6.3 ZYAK Flu (Influenza) Vaccine Major Product Offerings
7.6.4 ZYAK Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 ZYAK Key News & Latest Developments
7.7 SINOVAC
7.7.1 SINOVAC Company Summary
7.7.2 SINOVAC Business Overview
7.7.3 SINOVAC Flu (Influenza) Vaccine Major Product Offerings
7.7.4 SINOVAC Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 SINOVAC Key News & Latest Developments
7.8 Changsheng Biological
7.8.1 Changsheng Biological Company Summary
7.8.2 Changsheng Biological Business Overview
7.8.3 Changsheng Biological Flu (Influenza) Vaccine Major Product Offerings
7.8.4 Changsheng Biological Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Changsheng Biological Key News & Latest Developments
7.9 SIOBP
7.9.1 SIOBP Company Summary
7.9.2 SIOBP Business Overview
7.9.3 SIOBP Flu (Influenza) Vaccine Major Product Offerings
7.9.4 SIOBP Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 SIOBP Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Flu (Influenza) Vaccine Major Product Offerings
7.10.4 GSK Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 Aimei Hissen
7.11.1 Aimei Hissen Company Summary
7.11.2 Aimei Hissen Flu (Influenza) Vaccine Business Overview
7.11.3 Aimei Hissen Flu (Influenza) Vaccine Major Product Offerings
7.11.4 Aimei Hissen Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Aimei Hissen Key News & Latest Developments
7.12 Tianyuan Bio-pharma(Novartis)
7.12.1 Tianyuan Bio-pharma(Novartis) Company Summary
7.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Business Overview
7.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Major Product Offerings
7.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Tianyuan Bio-pharma(Novartis) Key News & Latest Developments
7.13 Simcere Vaxtec
7.13.1 Simcere Vaxtec Company Summary
7.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Business Overview
7.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Major Product Offerings
7.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Simcere Vaxtec Key News & Latest Developments
8 Global Flu (Influenza) Vaccine Production Capacity, Analysis
8.1 Global Flu (Influenza) Vaccine Production Capacity, 2018-2030
8.2 Flu (Influenza) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Flu (Influenza) Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Flu (Influenza) Vaccine Supply Chain Analysis
10.1 Flu (Influenza) Vaccine Industry Value Chain
10.2 Flu (Influenza) Vaccine Upstream Market
10.3 Flu (Influenza) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Flu (Influenza) Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Flu (Influenza) Vaccine in Global Market
Table 2. Top Flu (Influenza) Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Flu (Influenza) Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Flu (Influenza) Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Flu (Influenza) Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Flu (Influenza) Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Flu (Influenza) Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Flu (Influenza) Vaccine Product Type
Table 9. List of Global Tier 1 Flu (Influenza) Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Flu (Influenza) Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Flu (Influenza) Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Flu (Influenza) Vaccine Sales (K Units), 2024-2030
Table 16. By Application ? Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Flu (Influenza) Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Flu (Influenza) Vaccine Sales (K Units), 2024-2030
Table 21. By Region ? Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Flu (Influenza) Vaccine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Flu (Influenza) Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Flu (Influenza) Vaccine Sales (K Units), 2024-2030
Table 26. By Country - North America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Flu (Influenza) Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Flu (Influenza) Vaccine Sales, (K Units), 2024-2030
Table 30. By Country - Europe Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Flu (Influenza) Vaccine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Flu (Influenza) Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Flu (Influenza) Vaccine Sales, (K Units), 2024-2030
Table 34. By Region - Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Flu (Influenza) Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Flu (Influenza) Vaccine Sales, (K Units), 2024-2030
Table 38. By Country - South America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Flu (Influenza) Vaccine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Flu (Influenza) Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Flu (Influenza) Vaccine Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, (K Units), 2024-2030
Table 46. Hualan Bio Company Summary
Table 47. Hualan Bio Flu (Influenza) Vaccine Product Offerings
Table 48. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Hualan Bio Key News & Latest Developments
Table 50. CCBIO Company Summary
Table 51. CCBIO Flu (Influenza) Vaccine Product Offerings
Table 52. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. CCBIO Key News & Latest Developments
Table 54. Aleph Biomedical Company Summary
Table 55. Aleph Biomedical Flu (Influenza) Vaccine Product Offerings
Table 56. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Aleph Biomedical Key News & Latest Developments
Table 58. SANOFI Company Summary
Table 59. SANOFI Flu (Influenza) Vaccine Product Offerings
Table 60. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. SANOFI Key News & Latest Developments
Table 62. Adimmune Company Summary
Table 63. Adimmune Flu (Influenza) Vaccine Product Offerings
Table 64. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Adimmune Key News & Latest Developments
Table 66. ZYAK Company Summary
Table 67. ZYAK Flu (Influenza) Vaccine Product Offerings
Table 68. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. ZYAK Key News & Latest Developments
Table 70. SINOVAC Company Summary
Table 71. SINOVAC Flu (Influenza) Vaccine Product Offerings
Table 72. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. SINOVAC Key News & Latest Developments
Table 74. Changsheng Biological Company Summary
Table 75. Changsheng Biological Flu (Influenza) Vaccine Product Offerings
Table 76. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Changsheng Biological Key News & Latest Developments
Table 78. SIOBP Company Summary
Table 79. SIOBP Flu (Influenza) Vaccine Product Offerings
Table 80. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. SIOBP Key News & Latest Developments
Table 82. GSK Company Summary
Table 83. GSK Flu (Influenza) Vaccine Product Offerings
Table 84. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. GSK Key News & Latest Developments
Table 86. Aimei Hissen Company Summary
Table 87. Aimei Hissen Flu (Influenza) Vaccine Product Offerings
Table 88. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Aimei Hissen Key News & Latest Developments
Table 90. Tianyuan Bio-pharma(Novartis) Company Summary
Table 91. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Offerings
Table 92. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Tianyuan Bio-pharma(Novartis) Key News & Latest Developments
Table 94. Simcere Vaxtec Company Summary
Table 95. Simcere Vaxtec Flu (Influenza) Vaccine Product Offerings
Table 96. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Simcere Vaxtec Key News & Latest Developments
Table 98. Flu (Influenza) Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Flu (Influenza) Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Flu (Influenza) Vaccine Production by Region, 2018-2023 (K Units)
Table 101. Global Flu (Influenza) Vaccine Production by Region, 2024-2030 (K Units)
Table 102. Flu (Influenza) Vaccine Market Opportunities & Trends in Global Market
Table 103. Flu (Influenza) Vaccine Market Drivers in Global Market
Table 104. Flu (Influenza) Vaccine Market Restraints in Global Market
Table 105. Flu (Influenza) Vaccine Raw Materials
Table 106. Flu (Influenza) Vaccine Raw Materials Suppliers in Global Market
Table 107. Typical Flu (Influenza) Vaccine Downstream
Table 108. Flu (Influenza) Vaccine Downstream Clients in Global Market
Table 109. Flu (Influenza) Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Flu (Influenza) Vaccine Segment by Type in 2022
Figure 2. Flu (Influenza) Vaccine Segment by Application in 2022
Figure 3. Global Flu (Influenza) Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Flu (Influenza) Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Flu (Influenza) Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Flu (Influenza) Vaccine Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Flu (Influenza) Vaccine Revenue in 2022
Figure 9. By Type - Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 12. By Type - Global Flu (Influenza) Vaccine Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 16. By Application - Global Flu (Influenza) Vaccine Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Flu (Influenza) Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 21. By Country - North America Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 23. US Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 28. Germany Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. France Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 37. China Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. India Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 44. Brazil Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Flu (Influenza) Vaccine Sales Market Share, 2018-2030
Figure 48. Turkey Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Flu (Influenza) Vaccine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Flu (Influenza) Vaccine Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Flu (Influenza) Vaccine by Region, 2022 VS 2030
Figure 54. Flu (Influenza) Vaccine Industry Value Chain
Figure 55. Marketing Channels
